Refine by
Medicine Technology Articles & Analysis
110 news found
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. ...
Tempus, a leader in artificial intelligence and precision medicine, announced new testing solutions to help physicians identify patients with HER2 or FOLR1 expressing tumors, which may make such patients eligible for targeted therapies such as antibody–drug conjugates (ADCs). ...
ByTempus
Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker testing for patients with non-small cell lung cancer (NSCLC). ...
ByTempus
Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test portfolio, including Tempus’ xM test and the xM (NeXT Personal® Dx) test by Personalis. ...
ByTempus
"By helping healthcare companies easily build and manage AI solutions, we're enabling them to harness the full power and potential of generative AI." Dell Technologies (NYSE: DELL) and Northwestern Medicine are using AI to innovate and strengthen patient care to deliver significant advancements in medicine, including the development and ...
HLA typing, the process of identifying specific alleles within the HLA genes, is indispensable for personalized medicine, disease association studies, and achieving successful transplant outcomes. CD Genomics' HLA typing solutions integrate advanced NGS technologies, setting new standards for accuracy and reliability. Leveraging the power of NGS, their ...
CD Genomics remains committed to advancing genomics research and precision medicine by leveraging cutting-edge technologies and providing exceptional customer service. ...
In a groundbreaking move to revolutionize the field of biomedical research, Alfa Chemistry recently announced the launch of its highly anticipated custom organs-on-chips service. This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce ...
When the number of elderly people occupies a large proportion of the total population of society, concern for the life and health of the elderly is a topic for the whole society. With the development of technology, modern medicine plays an important role in the diagnosis and treatment of common diseases in the elderly. In order to maintain the quality of life ...
Substantial improvements in viral vector manufacturing, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. Viral vectors can be used for the treatment of various diseases such as: muscular, metabolic, hematologic, ophthalmologic, and infectious diseases as well as different types of cancer. An increasing number of clinical ...
ByNuvonis
Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI®, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI’s clinical research. ...
Built In today announced that Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, was honored in its 2023 Best Places To Work Awards. ...
This represents another step forward for AskBio in developing its gene editing and other nonviral delivery technologies and expertise. “The collaboration pairs AskBio’s expertise in synthetic DNA and CRISPR applications with ReCode’s novel SORT LNP delivery technology to potentially discover new genetic medicines,” said ...
ByBayer AG
Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Gastro Health, a national leading medical group specializing in digestive and liver health, to bring its AI Recruitment (AIR) technology to Gastro Health’s practices. ...
Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, today announced that it has been named one of CB Insights’ top 150 companies in Digital Health for 2022, the second year in a row in which it has made this list. ...
Latvian Biotechnology startup Longenesis has partnered with Dante Genomics, a global company of genomics and precision medicine, to offer whole genome sequencing (WGS) to more than 10,000 existing Longenesis study participants. ...
Iterative Health, formerly known as Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, has announced a rebrand to reflect the company’s success in utilizing artificial intelligence (AI) to strengthen clinical research and augment clinical decision making within gastroenterology. ...
He then set up the Grenoble Data Institute, a cross-disciplinary research group, to study how digital technology and data could be harnessed to benefit science and society. In 2019, he joined Owkin where, for the past three years, he has developed AI-based solutions to optimize clinical trials. ...
Local oncology centers are equipped with the latest technology, actively use innovative technologies and new medicines. In addition, oncology in the United States involves extensive screening and more aggressive anticancer treatment. ...
Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, and Provation, the premier software and SaaS provider of clinical productivity and workflow automation solutions, announced today that SKOUT™ has received 510(k) clearance from the U.S. ...